SLUPP 332
10mg/vial
Advanced Research Compound
Slupp 332 is a specialized lipolytic peptide formulation designed to target adipose tissue breakdown, enhance fat oxidation, and improve metabolic rate. Acting through adrenergic and lipase-mediated pathways, it promotes selective mobilization of stored fat — particularly from stubborn visceral and subcutaneous depots — without significant catabolic effects on lean muscle tissue.
Research Metrics
HPLC verified purity
Thermally stable compound
Water-soluble formulation
Pharmaceutical-grade
Mechanism of Action
Acts on adrenergic receptors (primarily beta-2 and beta-3) on adipocyte cell membranes, activating adenylyl cyclase and elevating intracellular cAMP. This activates protein kinase A (PKA), which phosphorylates hormone-sensitive lipase (HSL) and perilipin, enabling triglyceride hydrolysis. Peptide components also modulate PPAR-alpha pathways to enhance mitochondrial fatty acid uptake and beta-oxidation efficiency.
Scientific Benefits
- Targeted Lipolysis — Directly activates hormone-sensitive lipase (HSL) in adipocytes, triggering the breakdown of stored triglycerides into free fatty acids.
- Visceral Fat Reduction — Shows preferential activity against metabolically harmful visceral adipose tissue, reducing abdominal fat accumulation.
- Enhanced Fat Oxidation — Increases the rate at which mobilized free fatty acids are transported into mitochondria and oxidized for ATP production.
- Metabolic Rate Elevation — Upregulates basal metabolic rate through beta-adrenergic receptor sensitization and thermogenic pathway activation.
- Muscle Preservation — Targets fat stores preferentially, supporting lean body mass retention unlike non-selective catabolism from extreme dieting.
- Appetite Modulation — May exert mild appetite-suppressing effects via central signaling, supporting overall caloric deficit goals.
- Improved Insulin Sensitivity — Reduction in visceral fat mass is associated with downstream improvements in insulin receptor sensitivity and glucose homeostasis.
- Synergistic Potential — Combines effectively with GLP-1 agonists, GH peptides, and AOD-9604 in comprehensive body recomposition protocols.
Disclaimer & Usage Notice
GENERAL USAGE NOTICE. The products offered on this website are sold strictly for your own personal purposes. By purchasing, you acknowledge that you are assuming all risks associated with the handling and application of these products.
